VIRA THERAPEUTICS
ViraTherapeutics develops highly potent anti-cancer therapeutics based on oncolytic (cancer-destroying) viruses. Our proprietary oncolytic virus, VSV-GP, efficiently destroys cancer cells, while leaving normal tissues unharmed. ViraTherapeutics currently performs preclinical safety and efficacy studies for VSV-GP and aims to conduct first clinical trials in cancer patients.
VIRA THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2015-06-24
Address:
Innsbruck, Tirol, Austria
Country:
Austria
Website Url:
http://www.viratherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+43512272061
Email Addresses:
office(@)viratherapeutics.com
Total Funding:
3.6 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Domain Not Resolving Apache Organization Schema Microsoft Azure DNS
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Saiba
Saiba develops cutting-edge therapeutic and prophylactic vaccines.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Employees Featured
Founder
Investors List
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series A - Vira Therapeutics
EMBL Ventures
EMBL Ventures investment in Series A - Vira Therapeutics
aws Fondsmanagement GmbH
aws Fondsmanagement GmbH investment in Series A - Vira Therapeutics
Official Site Inspections
http://www.viratherapeutics.com
- Host name: 45.223.136.114
- IP address: 45.223.136.114
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
